1. |
Hib conjugate vaccine has impact in South Africa and Argentina |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
2. |
Six new drugs endorsed in Scotland |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
3. |
Whose rights are more important in emergency contraception? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
4. |
G-CSF not worth the extra cost in elderly patients with NHL |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
5. |
Intensive MRSA control programme cost saving in Sweden |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
6. |
Gemcitabine + cisplatin for NSCLC worthwhile in many countries |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 8-8
&NA;,
Preview
|
|
摘要:
Lung cancer is the leading cause of cancer deaths in the US, with non-small cell lung cancer (NSCLC) the most common form of the disease. Despite major advances in understanding and treating cancer, overall 5-year survival for patients diagnosed with lung cancer remains below 15%. However, even modest improvements in lung cancer mortality could have dramatic public health consequences. Indeed, preventing 10% of lung cancer deaths would save > 10 000 lives annually in the US. Gemcitabine is a novel nucleoside analogue with unique activity against a range of solid tumours including NSCLC and pancreatic cancer. According to its developer, Eli Lilly, in 2002 gemcitabine was"the preferred therapy in non-small cell lung cancer"worldwide. The economic effects of using gemcitabine in combination with cisplatin to treat NSCLC in various healthcare settings were assessed in several studies presented at a large poster session at the 7th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research [Hamburg, Germany; Oct 2004].
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
7. |
Ralfinamide,*a novel sodium channel blocker, may be effective in the treatment of neuropathic pain, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
8. |
IVIG during pregnancy attenuates neonatal haemochromatosis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
9. |
Modafinil helps combat sedative effect of SSRIs in depression |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
10. |
Influenza vaccination: intradermal route allows dose reduction |
|
Inpharma Weekly,
Volume &NA;,
Issue 1463,
2004,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|